Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Companion Diagnostic Technologies Market Status and Forecast (2017-2028)
  • 1.3.2 Global Companion Diagnostic Technologies Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Companion Diagnostic Technologies Supply by Company

• 2.1 Global Companion Diagnostic Technologies Sales Value by Company
• 2.2 Companion Diagnostic Technologies Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Companion Diagnostic Technologies Market Status by Type

• 3.1 Companion Diagnostic Technologies Type Introduction
  • 3.1.1 Immunohistochemistry
  • 3.1.2 Molecular Diagnostics
• 3.2 Global Companion Diagnostic Technologies Market by Type
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Companion Diagnostic Technologies Market Status by Application

• 4.1 Companion Diagnostic Technologies Segment by Application
  • 4.1.1 Oncology
  • 4.1.2 Cardiovascular
  • 4.1.3 Central Nervous System
  • 4.1.4 Auto immune & Inflammation
  • 4.1.5 Virology
  • 4.1.6 Others
• 4.2 Global Companion Diagnostic Technologies Market by Application
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Companion Diagnostic Technologies Market Status by Region

• 5.1 Global Companion Diagnostic Technologies Market by Region
• 5.2 North America Companion Diagnostic Technologies Market Status
• 5.3 Europe Companion Diagnostic Technologies Market Status
• 5.4 Asia Pacific Companion Diagnostic Technologies Market Status
• 5.5 Central & South America Companion Diagnostic Technologies Market Status
• 5.6 Middle East & Africa Companion Diagnostic Technologies Market Status

6 North America Companion Diagnostic Technologies Market Status

• 6.1 North America Companion Diagnostic Technologies Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Companion Diagnostic Technologies Market Status

• 7.1 Europe Companion Diagnostic Technologies Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Companion Diagnostic Technologies Market Status

• 8.1 Asia Pacific Companion Diagnostic Technologies Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Companion Diagnostic Technologies Market Status

• 9.1 Central & South America Companion Diagnostic Technologies Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Companion Diagnostic Technologies Market Status

• 10.1 Middle East & Africa Companion Diagnostic Technologies Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Companion Diagnostic Technologies Market Forecast by Type and by Application

• 12.1 Global Companion Diagnostic Technologies Sales Value Forecast (2023-2028)
• 12.2 Global Companion Diagnostic Technologies Forecast by Type
• 12.3 Global Companion Diagnostic Technologies Forecast by Application

13 Global Companion Diagnostic Technologies Market Forecast by Region/Country

• 13.1 Global Companion Diagnostic Technologies Market Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Thermo Fisher Scientific
  • 14.1.1 Company Information
  • 14.1.2 Companion Diagnostic Technologies Product Introduction
  • 14.1.3 Thermo Fisher Scientific Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Roche
  • 14.2.1 Company Information
  • 14.2.2 Companion Diagnostic Technologies Product Introduction
  • 14.2.3 Roche Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Resonance Health Ltd.
  • 14.3.1 Company Information
  • 14.3.2 Companion Diagnostic Technologies Product Introduction
  • 14.3.3 Resonance Health Ltd. Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 Qiagen
  • 14.4.1 Company Information
  • 14.4.2 Companion Diagnostic Technologies Product Introduction
  • 14.4.3 Qiagen Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Myriad Genetics
  • 14.5.1 Company Information
  • 14.5.2 Companion Diagnostic Technologies Product Introduction
  • 14.5.3 Myriad Genetics Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.5.4 SWOT Analysis
• 14.6 Leica Microsystems
  • 14.6.1 Company Information
  • 14.6.2 Companion Diagnostic Technologies Product Introduction
  • 14.6.3 Leica Microsystems Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.6.4 SWOT Analysis
• 14.7 Danaher
  • 14.7.1 Company Information
  • 14.7.2 Companion Diagnostic Technologies Product Introduction
  • 14.7.3 Danaher Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.7.4 SWOT Analysis
• 14.8 Dako (Agilent Technologies)
  • 14.8.1 Company Information
  • 14.8.2 Companion Diagnostic Technologies Product Introduction
  • 14.8.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.8.4 SWOT Analysis
• 14.9 bioMerieux
  • 14.9.1 Company Information
  • 14.9.2 Companion Diagnostic Technologies Product Introduction
  • 14.9.3 bioMerieux Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.9.4 SWOT Analysis
• 14.10 Abbott Laboratories
  • 14.10.1 Company Information
  • 14.10.2 Companion Diagnostic Technologies Product Introduction
  • 14.10.3 Abbott Laboratories Companion Diagnostic Technologies Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.10.4 SWOT Analysis

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Companion Diagnostic Technologies market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Companion Diagnostic Technologies industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Companion Diagnostic Technologies market is estimated at $ 3050 million in 2021, and projected to grow at a CAGR of 12.6% to $ 7010 million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Companion Diagnostic Technologies Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Technologies market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Companion Diagnostic Technologies Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Companion Diagnostic Technologies industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Immunohistochemistry
Molecular Diagnostics

Segmented by Application
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Thermo Fisher Scientific
Roche
Resonance Health Ltd.
Qiagen
Myriad Genetics
Leica Microsystems
Danaher
Dako (Agilent Technologies)
bioMerieux
Abbott Laboratories